Tech Company Financing Transactions
Lindus Health Funding Round
Lindus Health, based in London, England, secured $18 million in investment from Creandum, Amino Collective and Hambro Perks.
Transaction Overview
Company Name
Announced On
8/16/2023
Transaction Type
Venture Equity
Amount
$18,000,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to expand its technology platform to deliver more end-to-end clinical trials and quality data to research sponsors, and hire for a broad range of business development, clinical operations and operational roles.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
Taper Studios, The Leather Market Weston Street Unit A, Berm
London, England, SE1 3ER
UK
London, England, SE1 3ER
UK
Phone
Undisclosed
Website
Email Address
Overview
Operator of a tech-driven anti-contract research organization intended to deliver end-to-end clinical trials for health and biotech companies. The company's software platform accesses electronic health records, and designs and executes entire clinical trials end-to-end for life science companies, creating huge value for our customers by reducing their time to market and the risk of clinical trial failure, enabling health experts to capture more of the value chain, at higher margins, creating a sustainable competitive advantage.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Technical Officer
Nik Haldimann
Co-Founder
Michael Young
Browse more venture capital transactions:
Prev: 8/16/2023: OneBlinc venture capital transaction
Next: 8/16/2023: Toothio venture capital transaction
Share this article
Where The Data Comes From
We report on funding rounds that are announced publicly. VC investment data records on this site are derived from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs